sanofi news - Search News

Sanofi to sell 51% stake in Opella

Sanofi enters exclusive talks with CD&R for Opella sale

Sanofi said on Monday it had entered exclusive talks for the sale of a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R). The French pharmaceutical company,

Business Insider · 1h

Sanofi Enters Exclusive Negotiations To Sell 50% Stake In Opella To CD&R

Sanofi (SNYNF) announced it has entered into exclusive negotiations to sell a 50 percent controlling stake in its consumer healthcare

Leadership · 23m

Sanofi Sells Controlling Stake in Opella to CD&R with Job Guarantees

CD&R is nearing a deal to acquire control of Sanofi’s consumer health unit after it signed social commitments with the French government.

The Wall Street Journal on MSN · 2h

Sanofi Enters Exclusive Talks With CD&R Over Opella Stake Sale

Sanofi entered into exclusive talks to sell a controlling stake in its consumer-healthcare business Opella to Clayton Dubilier & Rice in a deal that values the business as a whole at 16 billion euros ($17.

Business Insider · 8h

Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI, Reuters reports

France will take a stake in Sanofi’s Opella through the Public Investment Bank, or BPI, finance minister Antoine Armand said on Sunday, confirming an information from Le Figaro

EconoTimes · 1h

Sanofi Enters Exclusive Talks to Sell 50% Stake in Opella to CD&R

Sanofis Exclusive Negotiations with Clayton Dubilier Rice Sanofi (NASDAQ: SNY) announced on Monday that it has entered exclusive negotiations to sell a 50% controlling stake in its consumer health division,

MarketWatch · 2h

Sanofi, CD&R in Exclusive Negotiations for Sale, Purchase of 50% Stake in Opella

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More. Back To Top

Reuters on MSN · 13h

Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI

France will take a stake in Sanofi's Opella through the Public Investment Bank (BPI), finance minister Antoine Armand said on Sunday, confirming an information from Le Figaro newspaper that U.S. private equity firm Clayton Dubilier & Rice (CD&R) is to take a 51% stake in the company that makes of one of France's most-sold painkillers,

11mon MSN

Sanofi in exclusive talks with CD&R over sale of $17 billion Opella

PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...

36m

Sanofi Pursues Sale Of Painkiller After Political Controversy

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after employment and investment guarantees relieved political controversy.

Daily38m

Sanofi closes deal for consumer health unit Opella: Report

The breakthrough came after the investment group provided France with guarantees on maintaining jobs and production in the ...

Sanofi Set to Sign Consumer Health Deal With CD&R This Weekend

Sanofi is aiming to sign an agreement this weekend to sell control of its consumer health business to Clayton Dubilier & Rice ...

Yahoo Finance6h

Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare

Sanofi and CD&R enter exclusive negotiations to transfer a 50% controlling stake in Opella with Sanofi to remain a significant shareholder With 11,000 talented and passionate people bringing ...